NCT06262321
Thoracic Radiotherapy for Patients With Metastatic (Stage IV) Non-Small Cell Lung Cancer at High Risk of Symptomatic Progression Within the Thorax No drug interventions treatment 2 recruiting NCT05652868
Clinical Study of Antibody-Drug Conjugate MYTX-011 in Subjects With Non-Small Cell Lung Cancer No drug interventions treatment 1 recruiting NCT05691829
Immunotherapy With Non-Ablative Radiation in Previously Untreated Patients With Stage IV NSCLC treatment 2 active_not_recruiting NCT06623786
Cancer Patient Remote Monitoring for Timely Communication Study No drug interventions Not Available Not Available not_yet_recruiting NCT05274451
A Study to Investigate LYL797 in Adults with Solid Tumors No drug interventions treatment 1 recruiting NCT05891197
A Biomarker Screening Protocol for Participants With Solid Tumors No drug interventions Not Available Not Available recruiting NCT06552234
Phase II Efficacy Study of Repotrectinib in Frail and/or Elderly Patients With ROS1-rearranged Advanced NSCLC treatment 2 not_yet_recruiting NCT04654364
Lung Cancer Registry No drug interventions Not Available Not Available recruiting NCT04633564
MYL-1402O Compared With Avastin®, in Patients With Stage IV nsNSCLC treatment 3 completed NCT04284202
PD-1 Combined With Dasatinib for as Third-line Treatment for ARID1A Mutation Advanced NSCLC treatment 2 unknown_status NCT05673187
Adagrasib in Patients With KRASG12C-mutant NSCLC Who Are Elderly or Have Poor Performance Status treatment 2 recruiting NCT05701787
Molecular Landscape Analysis and Clinical Implications for NSCLC Patients With Rare Mutations No drug interventions Not Available Not Available recruiting NCT06339554
Alectinib-induced Endocrine Toxicity Not Available Not Available completed NCT05055583
Toripalimab in Combination With Platinum-based Chemotherapy for Mutation-negative Stage IV Oligometastatic NSCLC treatment 2 unknown_status NCT04549428
Atezolizumab Plus 8 Gy Single-fraction Radiotherapy for Advanced Oligoprogressive NSCLC treatment 2 active_not_recruiting NCT04076228
Biomarkers to Predict the Response to Pembrolizumab in Chinese NSCLC Patients Not Available Not Available completed NCT05303493
Camu-Camu Prebiotic and Immune Checkpoint Inhibition in Patients With Non-small Cell Lung Cancer and Melanoma No drug interventions treatment 1 recruiting NCT06501378
Cranial Radiotherapy Plus Chemoimmunotherapy in Untreated Driver-mutation Negative NSCLC With Active Brain Metastasis No drug interventions treatment 2 recruiting NCT04767009
SBRT for Oligo-residual NSCLC After Treatment With PD-1/PD-L1 Immune Checkpoint Inhibitors No drug interventions treatment 2 recruiting NCT05344209
Efficacy and Safety of Anti-PD-1/PD-L1 Treatment +/- UV1 Vaccination in Patients With Non-small Cell Lung Cancer treatment 2 recruiting NCT03647956
Atezolizumab in Combination With Bevacizumab, Carboplatin and Pemetrexed for EGFR-mutant Metastatic NSCLC Patients After Failure of EGFR Tyrosine Kinase Inhibitors treatment 2 unknown_status NCT04908956
Osimertinib and Locally Ablative Radiotherapy in Patients With Synchronous Oligo-metastatic EGFR Mutant NSCLC (STEREO) treatment 2 terminated NCT03454685
The Role of Microbiota on the Development of Lung Cancer No drug interventions Not Available Not Available unknown_status NCT04745715
Genomic Study in Non-small Cell Lung Cancer Brain Metastasis No drug interventions Not Available Not Available completed NCT05597800
Nivolumab/Ipilimumab and Chemotherapy Combination in Advanced NSCLC Patients With HIV, HBV, HCV and Long Covid Syndrome treatment 2 not_yet_recruiting NCT03231475
Phase I Study of SPH1188-11 in NSCLC No drug interventions treatment 1 withdrawn NCT04636775
Microbiome in Immunotherapy naïve NSCLC Patients Receiving PD-1/L1 Blockade (MIP_NSCLC) No drug interventions Not Available Not Available recruiting NCT05816499
Cadonilimab in Patients (Pts) With Advanced Non-small Cell Lung Cancer (NSCLC) treatment 1 / 2 active_not_recruiting NCT04507906
Nivolumab Combined With Anlotinib as Re-challenge Treatment in Advanced NSCLC treatment 1 / 2 completed NCT05787613
A Clinical Study to Evaluate the Efficacy and Safety of HLX26 (Anti-LAG-3 Monoclonal Antibody Injection) Combined With Serplulimab and Chemotherapy in Previously Untreated Advanced NSCLC Patients treatment 2 recruiting NCT05132218
Ensatinib in alK-positive Patients Undergoing Initial Treatment for Advanced Non-small Cell Lung Cancer No drug interventions Not Available Not Available recruiting NCT04116918
Efficacy and Safety of the Combination of Anlotinib and JS001 in EGFR-TKI Resistant T790M-Negative NSCLC No drug interventions Not Available Not Available unknown_status NCT06219317
Immunotherapy Consolidation After Radical Treatment of Synchronous Oligo-metastatic NSCLC treatment 2 not_yet_recruiting NCT04507217
Tislelizumab Combined With Pemetrexed/ Carboplatin in Patients With Brain Metastases of Non-squamous NSCLC treatment 2 completed NCT03777124
Phase II Study of SHR-1210(Anti-PD-1 Antibody) Combination With Apatinib Versus Pemetrexed and Carboplatin in Subjects With KRAS Mutant Stage IV Non-squamous Non-small Cell Lung Cancer treatment 2 unknown_status NCT06401824
Sacituzumab Govitecan and Bevacizumab for NSCLC Brain Metastases treatment 2 not_yet_recruiting NCT04042558
A Study Evaluating Platinum-Pemetrexed-Atezolizumab (+/-Bevacizumab) for Patients With Stage IIIB/IV Non-squamous Non-small Cell Lung Cancer With EGFR Mutations, ALK Rearrangement or ROS1 Fusion Progressing After Targeted Therapies treatment 2 recruiting NCT04676386
Biomarker Analysis in High PD-L1 Expressing NSCLC Patients Treated With PD-1/PD-L1 Based Therapy With or Without the Addition of Platinum Based Chemotherapy No drug interventions Not Available Not Available terminated NCT05533086
PD-L1 PET Imaging in Patients With the Immunotherapy for Non-small Cell Lung Cancer No drug interventions Not Available Not Available recruiting NCT03363139
T790M Mutation Testing in Blood by Different Methodologies No drug interventions Not Available Not Available completed NCT06436625
Outpatient Pulmonary Rehabilitation in Non-small-cell Lung Cancer Receiving Immunotherapy No drug interventions supportive_care Not Available not_yet_recruiting NCT05332925
Using Ex Vivo Tumoroids To Predict Immunotherapy Response In NSCLC No drug interventions Not Available Not Available recruiting NCT05543330
A Phase Ib/II Clinical Trial of M701 in the Treatment of Malignant Pleural Effusions Caused by NSCLC treatment 1 / 2 not_yet_recruiting NCT05215548
Primary Tumor Resection With EGFR TKI for Stage IV NSCLC treatment 2 recruiting NCT05429320
A Study of Local Ablative Therapy (LAT) in People With Non-Small Cell Lung Cancer (NSCLC) No drug interventions treatment 2 recruiting NCT03594682
Optimizing the Therapeutic Dose of Apatinib Mesylate Tablets in Patients With Lung Cancer by Dose Titration：A Real World Exploratory Study No drug interventions treatment Not Available unknown_status NCT06523673
Stereotactic Body Radiotherapy for Oligo-Progression Metastatic Non-Small Cell Lung Cancer treatment 3 recruiting NCT03411473
Study of AGEN1884 With Pembrolizumab in 1L NSCLC treatment 2 terminated NCT04768491
Dacomitinib Treatment Followed by 3rd Generation EGFR-TKI in Patients With EGFR Mutation Positive Advanced NSCLC Not Available Not Available recruiting NCT06501391
Cranial Radiotherapy Plus Chemoimmunotherapy in Untreated Driver-mutation Negative NSCLC With Stable Brain Metastasis No drug interventions treatment 2 recruiting NCT03385980
Donation of Post Mortem Tumor Tissues No drug interventions Not Available Not Available completed NCT04291092
Camrelizumab Combined With Local Treatment in NSCLC Patients With BM treatment 2 unknown_status NCT03713944
Carboplatin Plus Pemetrexed Plus Atezolizumab Plus Bevacizumab in Chemotherapy and Immunotherapy-naïve Patients With Stage IV Non-squamous Non-small Cell Lung Cancer treatment 2 terminated NCT05387044
SBRT for Oligoprogressive NSCLC After First Line Treatment With Immune Checkpoint Inhibitors No drug interventions treatment 2 unknown_status NCT06218940
HY1272 in Patients With Locally Advanced or Metastatic Solid Tumors or Locally Advanced or Metastatic EGFRm+ NSCLC No drug interventions treatment 1 not_yet_recruiting NCT04467801
Ipatasertib and Docetaxel in Metastatic NSCLC Patients Who Have Failed 1st Line Immunotherapy treatment 2 recruiting NCT02735850
Combination of SABR and L19-IL2 in Patients With Stage IV Lung Cancer (ImmunoSABR) treatment 2 withdrawn NCT04467723
Combination of Atezolizumab and Pirfenidone in Second-line and Beyond NSCLC treatment 1 / 2 recruiting NCT03705403
IMMUNOtherapy and Stereotactic ABlative Radiotherapy (IMMUNOSABR) a Phase II Study treatment 2 active_not_recruiting NCT06234579
Longitudinal Assessment of Genomic Alterations and Clonal Evolution in ALK-positive NSCLC (Galileo Project) No drug interventions Not Available Not Available recruiting NCT04166487
Plasma-Adapted First-Line Pembro In NSCLC treatment 2 active_not_recruiting NCT04027647
Phase 2 Study of Dacomitinib in NSCLC treatment 2 active_not_recruiting NCT03564197
18F-PD-L1 PET/CT in Nivolumab Treated Patients With NSCLC No drug interventions diagnostic Not Available recruiting NCT03184571
Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With Advanced NSCLC treatment 2 completed NCT05311709
Sotorasib in Advanced KRASG12C-mutated Non-small Cell Lung Cancer Patients With Comorbidities treatment 2 recruiting NCT03515252
Study of Autologous Immune Killer Cells in Patients With Late Stage Hepatocellular Carcinoma or Lung Cancer No drug interventions treatment 1 completed NCT04521075
A Phase Ib Trial to Evaluate the Safety and Efficacy of FMT and Nivolumab in Subjects With Metastatic or Inoperable Melanoma, MSI-H, dMMR or NSCLC treatment 1 / 2 unknown_status NCT04604470
Trial-specific Patient Decision Aid (tPDA) of the ImmunoSABR Phase 2 No drug interventions Not Available Not Available unknown_status NCT05281406
Additional Chemotherapy for EGFRm Patients With the Continued Presence of Plasma ctDNA EGFRm at Week 3 After Start of Osimertinib 1st-line Treatment (PACE-LUNG) treatment 2 recruiting NCT06532149
ERectile Dysfunctions, gOnadotoxicity and Sexual Health Assessment in Men With Lung Cancer Not Available Not Available recruiting NCT06313541
Treatment Response Adapted Hybrid Radiotherapy in Metastatic Non-small Cell Lung Cancer Receiving First-line Immunotherapy treatment 2 recruiting NCT05859217
A Study of Combining Cabozantinib and Atezolizumab for Advanced/Metastatic NSCLC (Cabatezo-1) treatment 2 not_yet_recruiting NCT03960034
Cachexia in NSCLC Patients: Diagnosis, Characterization, Prognosis, Functional and Skeletal Muscle Implications No drug interventions Not Available Not Available completed NCT04909034
Safety and Potential Efficacy of MS-20 In Combination With Pembrolizumab for the Treatment of NSCLC No drug interventions treatment 2 unknown_status NCT04223596
Clinical Utility of Liquid Biopsy in Brigatinib ALK+ Patients treatment 2 active_not_recruiting NCT04136535
Pemetrexed and Carboplatin With or Without Anlotinib Hydrochloride for Osimertinib-resistant Non-squamous NSCLC treatment 2 unknown_status NCT05950139
Prophylactic Peptide Vaccine in Advanced ALK+ NSCLC No drug interventions treatment 1 / 2 recruiting NCT05212922
A Study to Evaluate YH001 in Combination With Toripalimab in Subjects With Advanced NSCLC and HCC treatment 2 withdrawn NCT03205930
Neo-MASCT Immunotherapy for Advanced NSCLC. No drug interventions treatment 1 / 2 unknown_status NCT04364620
AB-16B5 Combined With Docetaxel in Subjects With Metastatic Non-Small Cell Lung Cancer (EGIA-002) treatment 2 completed NCT04102982
Microwave Ablation in Combination With Camrelizumab Versus Camrelizumab in Metastatic Non-small-cell Lung Cancer other 2 unknown_status NCT05657873
A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC) treatment 2 recruiting NCT06374160
Exercise in Patients With Advanced Non-small Cell Lung Cancer No drug interventions supportive_care Not Available not_yet_recruiting NCT03341494
EGFR Mutation Positive NSCLC Patients With Gefitinib and Thalidomide treatment 2 unknown_status NCT04306094
Factors Determining the Prognosis in NSCLC Stage IV No drug interventions Not Available Not Available unknown_status NCT03808662
Randomized Study of Stereotactic Body Radiation Therapy (SBRT) in Patients With Oligoprogressive Metastatic Cancers of the Breast and Lung No drug interventions treatment 2 active_not_recruiting NCT04106180
SBRT in Combination With Sintilimab and GM-CSF for the Treatment of Advanced NSCLC treatment 2 unknown_status NCT03130829
To Evaluate the QoL Improvement of Oral Oligo Fucoidan in Subjects Receiving Platinum-based Chemotherapy With NSCLC No drug interventions supportive_care Not Available withdrawn NCT06207292
Stereotactic Ablative Radiotherapy in Synchronous and Metachronous Oligo-Metastatic Non Small Cell Lung Cancer No drug interventions treatment Not Available recruiting NCT04180501
SRS Sequential Sindilimab in Brain Metastasis of NSLSC treatment 2 unknown_status NCT05383001
Randomized Phase II, Open-label Efficacy and Safety Study of Second-line Durvalumab Plus Tremelimumab Versus Platinum-based Chemotherapy Alone in Patients With NSCLC and First-line Checkpoint-inhibitor Therapy (Re-Check) treatment 2 withdrawn NCT04613804
Toripalimab as Maintenance Therapy in Patients With Driver-gene Negative Advanced NSCLC After First-line Chemotherapy treatment 2 unknown_status NCT03620669
1st Line Durvalumab in PS 2 NSCLC Patients treatment 2 active_not_recruiting NCT04492969
Prospective Observation of Failure Patterns in NSCLC Treated With ICIs No drug interventions Not Available Not Available not_yet_recruiting NCT04764214
SRT for Residual Oligometastases of NSCLC After 3rd Generation EGFR-TKIs treatment 2 completed NCT03827850
FGFR Inhibitor in FGFR Dysregulated Cancer treatment 2 terminated NCT04932343
Comparison of Genomic and Transcriptomic Patterns Between CTC and Metastatic Tumormetastatic Tumor No drug interventions Not Available Not Available unknown_status NCT03368222
Pembrolizumab and SBRT in Metastatic Non-small-cell Lung Cancer Patients treatment 1 not_yet_recruiting NCT03402048
The EPIC Trial The Elderly Patient Individualized Chemotherapy Trial treatment 3 unknown_status NCT06064279
Harnessing Allo-immunity to Enhance Immune Checkpoint Inhibitor Responses in Advanced NSCLC treatment 1 / 2 withdrawn NCT05988697
Evaluate the Efficacy and Safety of Aspirin in Combination With Trametinib and Dabrafenib Not Available Not Available not_yet_recruiting NCT01438307
Phase II Study of Cabazitaxel-XRP6258 in Advanced Non-Small Cell Lung Cancer treatment 2 completed NCT01640730
Safety and Exploratory Efficacy of Kanglaite Injection in Non Small Cell Lung Cancer No drug interventions treatment 2 terminated NCT01864681
Combination of Metformin With Gefitinib to Treat NSCLC treatment 2 completed NCT03812549
Safety and Tolerability Evaluation of Sintilimab in Combination With Radiation in Stage IV NSCLC Patients treatment 1 completed NCT05631574
Study of Covalent Menin Inhibitor BMF-219 in Adult Patients With KRAS Driven Non-Small Cell Lung Cancer, Pancreatic Cancer, and Colorectal Cancer No drug interventions treatment 1 recruiting NCT04108026
Immunotherapy in Patient with Poor General Condition treatment 2 active_not_recruiting NCT06348199
A Study to Compare the Efficacy, Safety, Pharmacokinetics, and Immunogenicity Between SB27 and Keytruda in Subjects With Metastatic Non-squamous Non-small Cell Lung Cancer treatment 3 recruiting NCT06639191
[177Lu]Lu-AKIR001 First-in-human Study No drug interventions treatment 0 not_yet_recruiting NCT03526900
Atezolizumab in Combination With Carboplatin Plus Pemetrexed in Chemotherapy-naïve Patients With Asymptomatic Brain Metastasis treatment 2 completed NCT06463665
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer treatment 2 recruiting NCT04184921
Combination of Osimertinib and Aspirin to Treat EGFR Mutation NSCLC Patients Not Available Not Available unknown_status NCT01086254
SAR240550 in Combination With Gemcitabine/Cisplatin in Non-small Cell Lung Cancer treatment 2 completed NCT03275597
Phase Ib Study of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Non-small Lung Cancer (NSCLC) With Dual Immune Checkpoint Inhibition treatment 1 terminated NCT06463171
Phase II Trial of Almonertinib Plus Lastet for EGFR+ Non-small Cell Lung Cancer treatment 2 not_yet_recruiting NCT04432207
A Study of IMU-201 (PD1-Vaxx), a B-Cell Immunotherapy, in Adults With Non-Small Cell Lung Cancer treatment 1 active_not_recruiting NCT04289259
Tumor Mutational Burden in Lung Cancer Patients No drug interventions Not Available Not Available terminated NCT03692442
Evaluation of Efficacy and Toxicity of Nivolumab Monotherapy for Advanced Non-small Cell Lung Cancer After First-line Treatment Failure Based on Second-generation Sequencing and Liquid Chip Platform No drug interventions Not Available Not Available unknown_status NCT02129699
Survival imProvement in Lung cancEr iNduced by DenOsUmab theRapy treatment 3 terminated NCT05818449
Improvement of Personalized Lung Cancer Care Through Digital Connection and Patient Participation (DigiNet) No drug interventions treatment Not Available active_not_recruiting NCT06555263
Study to Investigate Luveltamab Tazevibulin in Adults With Advanced or Metastatic Non-small Cell Lung Cancer treatment 2 recruiting NCT02047344
Efficacy, Safety and Pharmacokinetics Study of Antroquinonol to Treat NSCLC treatment 2 completed NCT05055167
Envafolimab as First-line Treatment of Aged Patients in Advanced NSCLC treatment 2 active_not_recruiting NCT02176369
Maintenance Low Dose Oral Navelbine In Patients With Non Small Cell Lung Cancer - MA.NI.LA Trial treatment 2 completed NCT00766246
Phase II Avastin Trial for Stage IIIB/IV NSCLC treatment 2 terminated NCT03769103
Study of Osimertinib + SRS vs Osimertinib Alone for Brain Metastases in EGFR Positive Patients With NSCLC treatment 2 recruiting NCT05598853
Intrathecal Double Checkpoint Inhibition treatment 1 recruiting NCT03532698
Combination of Osimertinib and Aspirin to Treat Osimertinib Resistance Non-small Cell Lung Cancer ( NSCLC) Not Available Not Available unknown_status NCT03543683
Combination of Osimertinib and Aspirin to Treat 1st Generation EGFR-TKI Resistance in NSCLC Not Available Not Available unknown_status NCT03866993
A Study of Anti-PD-1 AK105 in Patients With Metastatic Squamous Non-small Cell Lung Cancer treatment 3 completed NCT01798485
A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC treatment 3 terminated NCT02450539
A Study of Abemaciclib (LY2835219) in Participants With Stage IV Squamous Non-small Cell Lung Cancer treatment 2 completed NCT01348126
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer treatment 2 / 3 terminated NCT05127382
Osimertinib as 1st Line Therapy for Patients With Advanced EGFR Positive Non-Small Cell Lung Cancer No drug interventions Not Available Not Available recruiting NCT01999673
Phase 3 Study of Bavituximab Plus Docetaxel Versus Docetaxel Alone in Patients With Late-stage Non-squamous Non-small-cell Lung Cancer treatment 3 completed NCT03866980
A Study of Anti-PD-1 AK105 in Patients With Metastatic Nonsquamous Non-small Cell Lung Cancer treatment 3 terminated NCT06436144
Osimertinib and Etoposide as First-Line Treatment in Osimertinib-Resistant Advanced EGFR-Mutant NSCLC treatment 2 not_yet_recruiting NCT06117644
The Efficacy of Double-dose Furmonertinib in the Treatment of Patients With Slow Osimertinib-resistant NSCLC No drug interventions Not Available Not Available not_yet_recruiting NCT04238169
Clinical Trial Assessing the Efficacy of Abscopal Effect Induced by SBRT and Immunotherapy in Advanced NSCLC treatment 2 completed NCT04082988
Early Response Evaluation in NSCLC Patients Treated With Immunotherapy No drug interventions diagnostic Not Available terminated NCT06512207
A Study on the Efficacy of Androgen Deprivation Therapy Combined With Anti-PD-1 Therapy in Advanced Lung Cancer treatment Not Available recruiting NCT03805841
Study of Tarloxotinib in Pts With NSCLC (EGFR Exon 20 Insertion, HER2-activating Mutations) & Other Solid Tumors With NRG1/ERBB Gene Fusions treatment 2 terminated NCT03083743
A Phase III Trial of Recombinant Human Apo-2 Ligand for Injection treatment 3 unknown_status NCT03499834
A Study to Evaluate the Safety and Efficacy of Ex Vivo Expanded Autologous Immune Killer Cells (IKC) in Stage IV Non-small Cell Lung Cancer (NSCLC) in Patients Who Failed Chemotherapy or Target Therapy No drug interventions treatment 2 completed NCT05361174
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer No drug interventions treatment 1 / 2 recruiting NCT06525246
Study of ONO-7475 in Combination With Osimertinib in EGFR Gene Mutation-positive Non-small Cell Lung Cancer treatment 1 active_not_recruiting NCT03559049
Rucaparib and Pembrolizumab for Maintenance Therapy in Stage IV Non-Squamous Non-Small Cell Lung Cancer treatment 1 / 2 active_not_recruiting NCT04906746
Ruxolitinib for Cancer Cachexia treatment 0 recruiting NCT05014815
Ociperlimab with Tislelizumab and Chemotherapy in Participants with Untreated Metastatic Non-Small Cell Lung Cancer treatment 2 completed NCT01249443
Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection treatment 1 terminated NCT00029003
Gefitinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer treatment 2 completed NCT02132884
Genetic Sequencing-Informed Targeted Therapy in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer No drug interventions treatment Not Available terminated NCT02581943
Effect of Pembrolizumab With or Without Carboplatin and Paclitaxel on Immune Response in Patients With Recurrent or Stage IIIB-IV Non-small Cell Lung Cancer treatment 2 completed NCT03742687
Heterogeneously Hypofractionated Radiotherapy for Locally Advanced NSCLC No drug interventions treatment Not Available recruiting NCT03987087
A Randomized Study of Primary Tumor Radiotherapy for Patients With MPE Stage IV NSCLC No drug interventions treatment 2 unknown_status NCT00088933
Vaccine Therapy and Sargramostim With or Without Docetaxel in Treating Patients With Metastatic Lung Cancer or Metastatic Colorectal Cancer treatment 1 terminated NCT01337154
First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung Cancer treatment 2 terminated NCT00075751
Gemcitabine, Carboplatin, and Bortezomib in Advanced or Recurrent Non-Small Cell Lung Cancer treatment 2 completed NCT01325753
Cryotherapy in Treating Patients With Lung Cancer That Has Spread to the Other Lung or Parts of the Body No drug interventions treatment Not Available withdrawn NCT00976677
Carboplatin, Paclitaxel, and Bevacizumab With or Without Erlotinib Hydrochloride in Treating Non-Smokers With Advanced Non-Small Cell Lung Cancer treatment 2 terminated NCT01935947
Azacitidine and Entinostat Before Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer treatment 2 terminated NCT04670445
Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer No drug interventions health_services_research Not Available active_not_recruiting NCT01014598
Cisplatin in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer or Lung Metastasis treatment 1 completed NCT00955305
Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer treatment 2 terminated NCT00068497
Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer treatment Not Available completed NCT02658097
Pembrolizumab Alone or Sequentially Following Single Fraction Non-ablative Radiation to One of the Target Lesions, in Previously Treated Patients With Stage IV NSCLC treatment 2 completed NCT00602797
Vinorelbine Tartrate and Paclitaxel in Treating Older Patients With Advanced Non-Small Cell Lung Cancer treatment 2 completed NCT00118183
Docetaxel With Either Cetuximab or Bortezomib as First-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer treatment 2 completed NCT02145078
Gene Expression Levels in Predicting Treatment Response in Patients With Stage IV Non-small Cell Lung Cancer treatment Not Available terminated NCT00481078
Vorinostat, Carboplatin, and Paclitaxel in Treating Patients With Advanced or Metastatic Non-Small Cell Lung Cancer treatment 2 completed NCT00042315
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase III Study of Tariquidar + Vinorelbine as First-Line Therapy in Non-Small Cell Lung Cancer (NSCLC) Not Available 3 terminated NCT03959137
BEPACT- Lung: Impact of Patient Characteristics on Pneumo-oncologists Non Small Cell Lung Cancer (NSCLC) Systemic Treatment Decision in Belgium No drug interventions Not Available Not Available completed NCT01723800
PI3K Inhibitor BKM120, Carboplatin, and Pemetrexed Disodium in Treating Patients With Stage IV Non-Small Cell Lung Cancer treatment 1 completed NCT03048500
Nivolumab and Metformin Hydrochloride in Treating Patients With Stage III-IV Non-small Cell Lung Cancer That Cannot Be Removed by Surgery treatment 2 unknown_status NCT01557959
Docetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer treatment 2 completed NCT01806675
18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy diagnostic 1 / 2 completed NCT04267575
Canady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor Sites No drug interventions treatment Not Available unknown_status NCT02897375
Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors treatment 1 completed NCT00459342
Dasatinib in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer treatment 2 completed NCT05588206
Dose-escalation by Hypofractionated Stereotactic Radiotherapy for Brain Metastases in Non Small Cell Lung Cancer No drug interventions treatment 1 / 2 recruiting NCT02655913
Safety and Efficacy of Vitamin C Infusion in Combination With Local mEHT to Treat Non Small Cell Lung Cancer treatment 1 / 2 completed NCT03049618
Recombinant EphB4-HSA Fusion Protein and Pembrolizumab, MK-3475 treatment 2 active_not_recruiting NCT01948141
Nintedanib in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Up to Two Previous Chemotherapy Regimens treatment 2 completed NCT01781741
Stereotactic Body Radiation Therapy After Surgery in Treating Patients With Stage III-IV Non-small Cell Lung Cancer No drug interventions treatment 0 completed NCT03121417
Nivolumab in Treating Patients With Advanced Metastatic Non-small Cell Lung Cancer treatment 2 withdrawn NCT04084717
Study of Crizotinib for ROS1 and MET Activated Lung Cancer treatment 2 recruiting NCT01131234
Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors treatment 1 completed NCT02819024
Dexamethasone Effects in Patients With Refractory Non-Small Cell Lung Cancer Using FLT Positron Emission Tomography diagnostic Not Available active_not_recruiting NCT02495896
Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors treatment 1 terminated NCT02650635
TLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients With Metastatic, Persistent, Recurrent, or Progressive Solid Tumors treatment 1 terminated NCT00300586
IFCT-GFPC 05.02 A Randomized Phase III Trial Assessing in Patients With Advanced Non-small Cell Lung Cancer treatment 3 completed NCT02947386
Nimotuzumab and Nivolumab in Treating Patients With Advanced Non-small Cell Lung Cancer treatment 1 completed NCT02438722
S1403, Afatinib Dimaleate With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage IV or Recurrent, EGFR Mutation Positive Non-small Cell Lung Cancer treatment 2 / 3 active_not_recruiting NCT00074022
GTI-2040 and Docetaxel in Treating Patients With Recurrent, Metastatic, or Unresectable Locally Advanced Non-Small Cell Lung Cancer, Prostate Cancer, or Other Solid Tumors treatment 1 / 2 completed NCT02451930
A Study of the Combination of Necitumumab (LY3012211) and Pembrolizumab (MK3475) in Participants With NSCLC treatment 1 completed NCT02243748
Palliative Care Intervention in Improving Symptom Control and Quality of Life in Patients With Stage II-IV Non-small Cell Lung Cancer and Their Family Caregivers No drug interventions supportive_care Not Available completed NCT02451865
Binimetinib With Docetaxel in Treating Patients With Previously Treated, Stage IV Non-small Cell Lung Cancer treatment 1 withdrawn NCT00387465
Azacitidine and Entinostat in Treating Patients With Recurrent Advanced Non-Small Cell Lung Cancer treatment 1 / 2 completed NCT00986674
Carboplatin and Paclitaxel Combined With Cetuximab and/or IMC-A12 in Patients With Advanced Non-Small Cell Lung Cancer treatment 2 completed NCT00387374
Radiation Therapy, Bevacizumab, Paclitaxel, and Carboplatin in Treating Patients With Unresectable Stage IIIB or Stage IV Non-Small Cell Lung Cancer at High Risk for Hemoptysis Caused by Bevacizumab treatment 2 completed NCT00937482
Cediranib Maleate and Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung Cancer treatment 1 terminated NCT00362882
Docetaxel and Bortezomib in Treating Patients With Progressive or Recurrent Non-Small Cell Lung Cancer treatment 2 completed NCT03176173
Radical-Dose Image Guided Radiation Therapy in Treating Patients With Metastatic Non-small Cell Lung Cancer Undergoing Immunotherapy No drug interventions treatment Not Available active_not_recruiting NCT01928160
Pemetrexed Disodium and Carboplatin or Cisplatin With or Without Erlotinib Hydrochloride in Treating Patient With Stage IV Non-Small Cell Lung Cancer Resistant to First-Line Therapy With Erlotinib Hydrochloride or Gefitinib treatment 2 withdrawn NCT00021060
Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer treatment 2 / 3 completed NCT06167460
Analysis of Circulating Tumor DNA Dynamics to Predict and Monitor Response to TKI in Patients With Advanced NSCLC. No drug interventions Not Available Not Available recruiting NCT02879994
Pembrolizumab in Treating Patients With EGFR Mutant, Tyrosine Kinase Inhibitor Naive Advanced Non-Small Cell Lung Cancer treatment 2 completed NCT02599194
18F-FSPG PET/CT for Cancer Patients on Therapy diagnostic 2 completed NCT03305380
Radiomics to Identify Patients at Risk for Developing Pneumonitis, Differentiate Immune Checkpoint Inhibitor-induced Pneumonitis From Other Lung Inflammation and Distinguish Tumour Pseudo-progression From Real Tumour Growth No drug interventions Not Available Not Available completed NCT00006929
Suramin, Paclitaxel, and Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer treatment 2 completed NCT00400829
E7389 in Treating Patients With Recurrent or Progressive Stage IIIB or Stage IV Non-Small Cell Lung Cancer treatment 2 completed NCT00368992
S0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung Cancer treatment 2 completed NCT03595644
Maintenance Targeted Therapy With or Without Stereotactic Body Radiation Therapy for Stage IV Non-small Cell Lung Cancer No drug interventions treatment 2 completed NCT01784640
Pemetrexed Disodium and Hsp90 Inhibitor AUY922 in Treating Patients With Previously Treated Stage IV Non-Small Cell Lung Cancer treatment 1 completed NCT00098540
Sorafenib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer treatment 2 completed NCT00066768
Suramin and Either Docetaxel or Gemcitabine in Treating Patients With Stage IIIB or Stage IV Platinum-Refractory Non-Small Cell Lung Cancer treatment 1 completed NCT01193868
RO4929097 in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Recently Completed Treatment With Front-Line Chemotherapy treatment 2 terminated NCT02073968
PET-Adjusted Intensity Modulated Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II-IV Non-small Cell Lung Cancer treatment 2 completed NCT02470468
Evaluation of Safety and Efficacy of DCVAC/LuCa (Immunotherapy of Lung Cancer) in Patients With Metastatic Lung Cancer No drug interventions treatment 1 / 2 completed NCT00040768
Bortezomib in Treating Patients With Advanced Non-small Cell Lung Cancer treatment 2 terminated NCT00003869
Carboxyamidotriazole in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer treatment 3 completed NCT02134912
S1300: Pemetrexed Disodium With or Without Crizotinib in Treating Patients With Stage IV Non-Small Cell Lung Cancer That Has Progressed After Crizotinib treatment 2 terminated NCT01193881
RO4929097 and Erlotinib Hydrochloride in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer treatment 1 terminated NCT00084981
Decitabine and Valproic Acid in Treating Patients With Non-Small Cell Lung Cancer treatment 1 completed NCT00031681
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) treatment 1 completed NCT02400814
MPDL3280A and Stereotactic Ablative Radiotherapy in Patients With Non-small Cell Lung Cancer treatment 1 terminated NCT00655655
Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors treatment 1 completed NCT00499655
Erlotinib Hydrochloride With or Without Celecoxib in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer treatment 2 completed NCT00138203
Suberoylanilide Hydroxamic Acid in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer treatment 2 completed NCT03154190
Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer No drug interventions health_services_research Not Available unknown_status NCT02823990
TG4010 and Nivolumab in Patients With Lung Cancer treatment 2 completed NCT01620190
Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Previously Treated Advanced Non-small Cell Lung Cancer treatment 2 completed NCT02566421
Genomic Sequencing in Determining Treatment in Patients With Metastatic Cancer or Cancer That Cannot Be Removed by Surgery No drug interventions treatment Not Available terminated NCT00042302
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase III Study of Tariquidar + Paclitaxel/Carboplatin as First-Line Therapy in Non-Small Cell Lung Cancer (NSCLC) Not Available 3 terminated NCT00020202
FR901228 in Treating Patients With Refractory or Progressive Small Cell Lung Cancer or Non-small Cell Lung Cancer treatment 2 completed NCT01737502
Sirolimus and Auranofin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer or Small Cell Lung Cancer treatment 1 / 2 completed NCT00397384
Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer treatment 1 completed NCT01282333
Veliparib, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Biliary, Pancreatic, Urothelial, or Non-Small Cell Lung Cancer treatment 1 terminated NCT05675033
Serplulimab Combined With Anti-VEGF Antibody in Advanced Lung Adenocarcinoma treatment 2 not_yet_recruiting NCT00564733
FDG-Labeled PET Scan in Planning Chemotherapy in Treating Patients With Stage IIIB or IV Non-Small Cell Lung Cancer treatment 2 completed NCT01664754
Exemestane, Pemetrexed Disodium, and Carboplatin in Treating Post-Menopausal Women With Stage IV Non-Small Cell Lung Cancer treatment 1 completed NCT03199651
Beating Lung Cancer in Ohio Protocol in Improving Survival in Patients With Stage IV Non-Small Cell Lung Cancer No drug interventions health_services_research Not Available recruiting NCT04056247
Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments No drug interventions Not Available Not Available recruiting NCT00030498
Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction treatment 1 completed NCT00003497
Antineoplaston Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer treatment 2 terminated NCT00004883
Trastuzumab in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer That Overexpresses HER2 treatment 2 completed NCT01217411
RO4929097 and Whole-Brain Radiation Therapy or Stereotactic Radiosurgery in Treating Patients With Brain Metastases From Breast Cancer treatment 1 terminated NCT03137771
Maintenance Chemotherapy With or Without Local Consolidative Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer treatment 2 active_not_recruiting NCT00088088
STA-4783 in Combination With Paclitaxel and Carboplatin for the Treatment of Chemotherapy Naive Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC) treatment 1 / 2 completed NCT00963807
A Comparison of FLT to FDG PET/CT in the Early Assessment of Chemotherapy Response in Stage IB-IIIA Resectable NSCLC treatment 2 completed NCT05583409
SBRT Combined With Osimertinib Compared With Osimertinib for Stage IV NSCLC treatment Not Available not_yet_recruiting NCT02364609
Pembrolizumab and Afatinib in Patients With Non-small Cell Lung Cancer With Resistance to Erlotinib treatment 1 completed NCT00638937
AZD0530 to Treat Recurrent Stage IIIB/IV NSCLC Previously Treated With Combination Chemotherapy treatment 2 completed NCT01528137
Talactoferrin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer or Squamous Cell Head and Neck Cancer treatment 1 terminated NCT01658332
Circulating Tumor Cells in Lung Cancer No drug interventions diagnostic Not Available terminated NCT02245100
Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung Cancer No drug interventions Not Available Not Available completed NCT00088959
Celecoxib and Erlotinib in Treating Former Smokers With Stage IIIB or Stage IV Non-Small Cell Lung Cancer treatment 1 completed NCT02106559
Photodynamic Therapy During Surgery in Treating Patients With Pleural Malignancy treatment Not Available withdrawn NCT02009436
Azacitidine in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer treatment 1 completed NCT01935336
Study of Ponatinib in Patients With Lung Cancer Preselected Using Different Candidate Predictive Biomarkers treatment 2 completed NCT03911219
Impact of eHealth Monitoring on Overall Survival in Patients With Metastatic NSCLC / Extensive-stage SCLC / Advanced TNBC Under First-line Treatment With Atezolizumab Plus Chemotherapy No drug interventions Not Available Not Available completed NCT03119519
Local Non-salvage Radiotherapy for Synchronous Oligometastatic Non-small-cell Lung Cancer. No drug interventions treatment 2 unknown_status NCT02206334
Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate Cancer No drug interventions treatment 1 completed NCT00247416
Effects of Carboplatin and Gemcitabine on Stage IIIB Pleural Effusion and Stage IV Lung Cancer treatment 2 completed NCT02567396
Talazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney Dysfunction treatment 1 withdrawn NCT02728596
S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER) No drug interventions health_services_research Not Available completed NCT01155258
Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors treatment 1 completed NCT00228358
Cyclophosphamide or Denileukin Diftitox Followed By Expanding a Patient's Own T Cells in the Laboratory in Treating Patients With HER-2/Neu Overexpressing Metastatic Breast Cancer, Ovarian Cancer, or Non-Small Cell Lung Cancer Previously Treated With HER-2/Neu Vaccine treatment 1 completed NCT02426658
Pemetrexed Disodium in Treating Patients With Stage IV Non-small Cell Lung Cancer and ECOG Performance Status 3 treatment 2 completed NCT00079235
CCI-779 in Treating Patients With Stage IIIB (With Pleural Effusion) or Stage IV Non-Small Cell Lung Cancer treatment 2 completed NCT04900935
Patient-centered, Optimal Integration of Survivorship and Palliative Care No drug interventions supportive_care Not Available recruiting NCT02178163
Comprehensive Genomic Analysis in Tissue Samples From Patients With Recurrent or Stage IV Non-small Cell Lung Cancer No drug interventions other Not Available recruiting NCT02134886
Erlotinib Hydrochloride in Treating Non-Small Cell Lung Cancer That is Metastatic or Cannot be Removed by Surgery in Patients With HIV Infection treatment 1 terminated NCT02017925
Pulmonary Rehabilitation in Improving Lung Function in Patients With Locally Advanced Non-Small Cell Lung Cancer Undergoing Chemoradiation No drug interventions supportive_care Not Available withdrawn NCT03838848
KN046 in Patients With Advanced Non-small Cell Lung Cancer treatment 2 terminated NCT00101348
Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer treatment 1 / 2 completed NCT00055757
Tipifarnib, Gemcitabine, and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer treatment 2 completed NCT00950365
Pemetrexed Disodium With or Without Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV or Recurrent Non-Small Cell Lung Cancer treatment 2 completed NCT00004074
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu treatment 1 completed NCT04654520
A Randomized Study of Primary Tumor Radiotherapy for Patients With Stage Ⅳ NSCLC No drug interventions treatment Not Available unknown_status NCT01004731
Study of Anti-Epidermal Growth Factor Receptor (EGFr) Antibody, Cetuximab, in Combination With Gemcitabine/Carboplatin in Patients With Stage IV Lung Cancer treatment 1 / 2 completed NCT04142931
Sequentional Immuno Apheresis Plasma Volume Escalation Cohort Study of Reduction of Soluble Tumor Necrosis Factor Receptors 1 and 2 (sTNFR1/2) With or Without Nivolumab in Patients With Inoperable or Metastatic Solid Tumors treatment 1 unknown_status NCT00408460
Imatinib Mesylate and Paclitaxel in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer treatment 2 completed NCT02831491
A Study of Ramucirumab (LY3009806) in Combination With Weekly Docetaxel in Participants With Stage IV Non-Small Cell Lung Cancer treatment 2 withdrawn NCT00087191
EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer diagnostic Not Available terminated NCT00039091
Monoclonal Antibody Therapy in Treating Patients With Ovarian Epithelial Cancer, Melanoma, Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Non-Small Cell Lung Cancer treatment 1 terminated NCT05681780
Clinical Trial of CD40L-Augmented TIL for Patients With EGFR, ALK, ROS1 or HER2-Driven NSCLC treatment 1 / 2 recruiting NCT00085280
Erlotinib in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer treatment Not Available completed NCT01729689
Cognitive Behavioral Therapy in Treating Anxiety in Patients With Stage IV Non-Small Cell Lung Cancer and Their Caregivers No drug interventions supportive_care Not Available completed NCT01971489
Buparlisib, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid Tumors treatment 1 withdrawn NCT00118144
Bortezomib in Treating Patients With Stage IIIB or Stage IV Lung Cancer treatment 2 completed NCT01310244
MTD Study PXD-101 in Combination With Paclitaxel + Carboplatin in Chemotherapy-Naive Patients With Stage IV NSCLC treatment 1 / 2 completed NCT05176067
Randomized Controlled Clinical Study of Drug Therapy Combined With Thoracic Radiotherapy for Non-oligometastatic NSCLC No drug interventions treatment Not Available unknown_status NCT01026467
Frailty Index and Geriatric Assessment in Predicting Toxicity to Front-Line Chemotherapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer Not Available Not Available completed NCT00778167
Erlotinib Hydrochloride With or Without Cixutumumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer treatment 1 / 2 completed NCT00062101
Erlotinib and Celecoxib in Treating Patients With Stage IIIB or Stage IV Recurrent Non-Small Cell Lung Cancer treatment 2 completed NCT03023904
Nivolumab in Treating Patients With Stage IV or Recurrent Lung Cancer With High Mutation Loads treatment 2 withdrawn NCT01383668
Sirolimus and Gold Sodium Thiomalate in Treating Patients With Advanced Squamous Non-Small Cell Lung Cancer treatment 1 withdrawn NCT02858869
Pembrolizumab and Stereotactic Radiosurgery for Melanoma or Non-Small Cell Lung Cancer Brain Metastases treatment 1 completed NCT02045446
Maintenance Chemotherapy Versus Consolidative Stereotactic Body Radiation Therapy (SBRT) Plus Maintenance Chemotherapy for Stage IV Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II Trial No drug interventions treatment 2 completed NCT00087412
S0341: Erlotinib in Treating Patients With Advanced Primary Non-Small Cell Lung Cancer treatment 2 completed NCT01999881
Impacts of Exercise on Prognostic Biomarkers in Lung Cancer Patients No drug interventions supportive_care Not Available completed NCT00738881
Pemetrexed Disodium or Erlotinib Hydrochloride as Second-Line Therapy in Treating Patients With Advanced Non-small Cell Lung Cancer treatment 3 terminated NCT00063895
Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and Neck treatment 1 / 2 completed NCT01839955
Erlotinib Hydrochloride and Quinacrine Dihydrochloride in Stage IIIB-IV Non-Small Cell Lung Cancer treatment 1 completed NCT01413750
Carboplatin and Paclitaxel With or Without Vorinostat in Treating Patients With Advanced Non-Small Cell Lung Cancer treatment 1 / 2 terminated NCT05566223
CISH Inactivated TILs in the Treatment of NSCLC treatment 1 / 2 not_yet_recruiting NCT04530708
Addition of Radiotherapy to Standard Medical Treatment for Stage IV NSCLC No drug interventions treatment Not Available recruiting NCT03087708
Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer supportive_care 2 terminated NCT03611738
Ceritinib Plus Docetaxel in ALK-Negative, EGFR WT Advanced NSCLC treatment 1 active_not_recruiting NCT00052338
Bortezomib Plus Gemcitabine and Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer treatment 1 completed NCT02949843
Targeted Therapy in Treating Patients With Incurable Non-Small Cell Lung Cancer With Genetic Mutations treatment 2 terminated NCT02312622
Phase 2 Etirinotecan Pegol in Refractory Brain Metastases & Advanced Lung Cancer / Metastatic Breast Cancer treatment 2 completed NCT01515969
Phase 1 Erlotinib and Dovitinib (TKI258) in Advanced Non-small Cell Lung Cancer (NSCLC) treatment 1 terminated